The stock has a 36-month beta value of 0.05. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MAIA is 22.07M, and at present, short sellers hold a 2.61% of that float. On May 15, 2025, the average trading volume of MAIA was 199.78K shares.
MAIA) stock’s latest price update
The stock price of MAIA Biotechnology Inc (AMEX: MAIA) has surged by 10.80 when compared to previous closing price of 1.76, but the company has seen a -0.51% decline in its stock price over the last five trading sessions. businesswire.com reported 2025-05-15 that CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting.
MAIA’s Market Performance
MAIA Biotechnology Inc (MAIA) has experienced a -0.51% fall in stock performance for the past week, with a 24.20% rise in the past month, and a 4.28% rise in the past quarter. The volatility ratio for the week is 7.68%, and the volatility levels for the past 30 days are at 13.17% for MAIA. The simple moving average for the last 20 days is -1.89% for MAIA stock, with a simple moving average of -13.49% for the last 200 days.
MAIA Trading at 11.39% from the 50-Day Moving Average
After a stumble in the market that brought MAIA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.45% of loss for the given period.
Volatility was left at 13.17%, however, over the last 30 days, the volatility rate increased by 7.68%, as shares surge +26.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.65% upper at present.
During the last 5 trading sessions, MAIA fell by -0.61%, which changed the moving average for the period of 200-days by -39.88% in comparison to the 20-day moving average, which settled at $1.9874. In addition, MAIA Biotechnology Inc saw -1.52% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MAIA starting from Guerrero Ramiro, who purchase 20,000 shares at the price of $1.50 back on May 08 ’25. After this action, Guerrero Ramiro now owns 588,218 shares of MAIA Biotechnology Inc, valued at $30,000 using the latest closing price.
Smith Stan, the Director of MAIA Biotechnology Inc, purchase 66,666 shares at $1.50 during a trade that took place back on May 08 ’25, which means that Smith Stan is holding 1,271,726 shares at $99,999 based on the most recent closing price.
Stock Fundamentals for MAIA
The total capital return value is set at -2.71. Equity return is now at value -1131.02, with -191.48 for asset returns.
Currently, EBITDA for the company is -16.96 million with net debt to EBITDA at 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.35.
Conclusion
To sum up, MAIA Biotechnology Inc (MAIA) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
